1. P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states. (15th November 2016) Authors: Maher, T; Noth, I; Allinger, A; Kaul, M; Conoscenti, CS; Oelberg, D Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗